A novel immune regulatory peptide, PEPITEM (peptide inhibitor of trans-endothelial migration), controls T-cell trafficking during inflammation, a tonic inhibitory pathway that is lost in Type 1 diabetes
Journal article published in 2014 by
M. Chimen 
,
H. M. McGettrick,
C. M. Yates,
A. Kennedy,
A. Martin,
F. Barone,
L. S. K. Walker,
C. D. Buckley,
G. B. Nash,
G. E. Rainger,
P. Narendran
,
H. M. McGettrick,
C. M. Yates,
A. Kennedy,
A. Martin,
F. Barone,
L. S. K. Walker,
C. D. Buckley,
G. B. Nash,
G. E. Rainger,
P. Narendran
